Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Schipper

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
Advances in Radiation Oncology|October 30, 2018
A simulation study to assess the potential impact of developing normal tissue complication probability models with accumulated doseMolly M McCulloch, Daniel G Muenz, Matthew J Schipper, et al.
Archives of Internal Medicine|June 10, 2009
Medical decision making regarding computed tomographic radiation dose and associated risk: the patient's perspectiveElaine M Caoili, Richard H Cohan, James H Ellis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 27, 2023
Single-Time-Point Imaging for Dosimetry After [<sup>177</sup>Lu]Lu-DOTATATE: Accuracy of Existing Methods and Novel Data-Driven Models for Reducing Sensitivity to Time-Point SelectionChang Wang, Avery B Peterson, Ka Kit Wong, et al.
Statistics in Medicine|August 29, 2014
Personalized dose selection in radiation therapy using statistical models for toxicity and efficacy with dose and biomarkers as covariatesMatthew J Schipper, Jeremy M G Taylor, Randy TenHaken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Assessing the benefit of radiation therapy after breast-conserving surgery for ductal carcinoma-in-situJames A Hayman, Mohammed U Kabeto, Matthew J Schipper, et al.
The Breast Journal|May 6, 2004
A phase I dose escalation trial of gemcitabine with radiotherapy for breast cancer in the treatment of unresectable chest wall recurrencesW Warren Suh, Anne F Schott, James A Hayman, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 10, 2013
Biological-effect modeling of radioimmunotherapy for non-hodgkins lymphoma: determination of model parametersPeter L Roberson, Scott J Wilderman, Anca M Avram, et al.
Frontiers in Oncology|September 16, 2017
Big Data in Designing Clinical Trials: Opportunities and ChallengesCharles S Mayo, Martha M Matuszak, Matthew J Schipper, et al.
Abdominal Imaging|February 7, 2008
Detection of upper tract urothelial neoplasms: sensitivity of axial, coronal reformatted, and curved-planar reformatted image-types utilizing 16-row multi-detector CT urographyJonathan R Dillman, Elaine M Caoili, Richard H Cohan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 2019
Prediction of Tumor Control in <sup>90</sup>Y Radioembolization by Logit Models with PET/CT-Based Dose MetricsYuni K Dewaraja, Theresa Devasia, Ravi K Kaza, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Advances in Radiation Oncology|October 30, 2018
A simulation study to assess the potential impact of developing normal tissue complication probability models with accumulated doseMolly M McCulloch, Daniel G Muenz, Matthew J Schipper, et al.
Archives of Internal Medicine|June 10, 2009
Medical decision making regarding computed tomographic radiation dose and associated risk: the patient's perspectiveElaine M Caoili, Richard H Cohan, James H Ellis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 27, 2023
Single-Time-Point Imaging for Dosimetry After [<sup>177</sup>Lu]Lu-DOTATATE: Accuracy of Existing Methods and Novel Data-Driven Models for Reducing Sensitivity to Time-Point SelectionChang Wang, Avery B Peterson, Ka Kit Wong, et al.
Statistics in Medicine|August 29, 2014
Personalized dose selection in radiation therapy using statistical models for toxicity and efficacy with dose and biomarkers as covariatesMatthew J Schipper, Jeremy M G Taylor, Randy TenHaken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Assessing the benefit of radiation therapy after breast-conserving surgery for ductal carcinoma-in-situJames A Hayman, Mohammed U Kabeto, Matthew J Schipper, et al.
The Breast Journal|May 6, 2004
A phase I dose escalation trial of gemcitabine with radiotherapy for breast cancer in the treatment of unresectable chest wall recurrencesW Warren Suh, Anne F Schott, James A Hayman, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 10, 2013
Biological-effect modeling of radioimmunotherapy for non-hodgkins lymphoma: determination of model parametersPeter L Roberson, Scott J Wilderman, Anca M Avram, et al.
Frontiers in Oncology|September 16, 2017
Big Data in Designing Clinical Trials: Opportunities and ChallengesCharles S Mayo, Martha M Matuszak, Matthew J Schipper, et al.
Abdominal Imaging|February 7, 2008
Detection of upper tract urothelial neoplasms: sensitivity of axial, coronal reformatted, and curved-planar reformatted image-types utilizing 16-row multi-detector CT urographyJonathan R Dillman, Elaine M Caoili, Richard H Cohan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 2019
Prediction of Tumor Control in <sup>90</sup>Y Radioembolization by Logit Models with PET/CT-Based Dose MetricsYuni K Dewaraja, Theresa Devasia, Ravi K Kaza, et al.
Pageof 13